GSA Capital Partners’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

GSA Capital Partners’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-61,640	Closed	-$360K	–	1964
2022 Q2	$360K	Buy	61,640 +24,212	+65%	+$137K	0.05%	712
2022 Q1	$266K	Buy	37,428 +3,552	+10%	+$34.8K	0.04%	985
2021 Q4	$447K	Sell	33,876 -3,605	-10%	-$59.6K	0.06%	673
2021 Q3	$862K	Buy	+37,481	New	+$1.12M	0.09%	378
2021 Q2	–	Sell	-27,638	Closed	-$2.01M	–	1673
2021 Q1	$2.01M	Buy	27,638 +26,568	+2,483%	+$1.89M	0.33%	43
2020 Q4	$46K	Sell	1,070 -65	-6%	-$2.91K	0.01%	1139
2020 Q3	$47K	Sell	1,135 -936	-45%	-$48.4K	0.01%	1187
2020 Q2	$124K	Buy	+2,071	New	+$190K	0.07%	446

Other funds holding ORTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

GSA Capital Partners's ORTX Position: Q3 2022 in Review

GSA Capital Partners sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2022, closing a stake of 61,640 shares — an estimated $360K sold.

GSA Capital Partners first reported a position in ORTX in Q2 2020 and held it in 8 quarters. The position peaked at $2.01M in Q1 2021. 47 funds tracked by Wall St. Rank hold ORTX as of Q3 2022.

GSA Capital Partners reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2022 after selling out during the quarter.
GSA Capital Partners sold 61,640 Orchard Therapeutics plc American Depositary Shares shares in Q3 2022, an estimated $360K.
GSA Capital Partners first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2020 and held it in 8 quarters.
GSA Capital Partners's Orchard Therapeutics plc American Depositary Shares position peaked at $2.01M in Q1 2021.
47 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2022.

Based on GSA Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.